191 related articles for article (PubMed ID: 35767377)
1. A 3D Osteosarcoma Model with Bone-Mimicking Cues Reveals a Critical Role of Bone Mineral and Informs Drug Discovery.
González Díaz EC; Lee AG; Sayles LC; Feria C; Sweet-Cordero EA; Yang F
Adv Healthc Mater; 2022 Sep; 11(17):e2200768. PubMed ID: 35767377
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of endothelin A receptor expression inhibits osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse model.
Li Y; Liao Q; Li K; Zhong D; Weng X; Mi M
Mol Med Rep; 2012 Jun; 5(6):1391-5. PubMed ID: 22446894
[TBL] [Abstract][Full Text] [Related]
3. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
4. Bioengineering a humanized 3D tri-culture osteosarcoma model to assess tumor invasiveness and therapy response.
Monteiro CF; Custódio CA; Mano JF
Acta Biomater; 2021 Oct; 134():204-214. PubMed ID: 34303015
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma Patient-derived Orthotopic Xenograft (PDOX) Models Used to Identify Novel and Effective Therapeutics: A Review.
Higuchi T; Igarashi K; Yamamoto N; Hayashi K; Kimura H; Miwa S; Bouvet M; Tsuchiya H; Hoffman RM
Anticancer Res; 2021 Dec; 41(12):5865-5871. PubMed ID: 34848441
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a patient-derived orthotopic osteosarcoma mouse model.
Blattmann C; Thiemann M; Stenzinger A; Roth EK; Dittmar A; Witt H; Lehner B; Renker E; Jugold M; Eichwald V; Weichert W; Huber PE; Kulozik AE
J Transl Med; 2015 Apr; 13():136. PubMed ID: 25926029
[TBL] [Abstract][Full Text] [Related]
7. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
[TBL] [Abstract][Full Text] [Related]
8. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
[TBL] [Abstract][Full Text] [Related]
9. Hydrogel 3D in vitro tumor models for screening cell aggregation mediated drug response.
Monteiro MV; Gaspar VM; Ferreira LP; Mano JF
Biomater Sci; 2020 Mar; 8(7):1855-1864. PubMed ID: 32091033
[TBL] [Abstract][Full Text] [Related]
10. Relevance of 3d culture systems to study osteosarcoma environment.
De Luca A; Raimondi L; Salamanna F; Carina V; Costa V; Bellavia D; Alessandro R; Fini M; Giavaresi G
J Exp Clin Cancer Res; 2018 Jan; 37(1):2. PubMed ID: 29304852
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
[TBL] [Abstract][Full Text] [Related]
12. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
[TBL] [Abstract][Full Text] [Related]
13. Role of aldolase A in osteosarcoma progression and metastasis: in vitro and in vivo evidence.
Long F; Cai X; Luo W; Chen L; Li K
Oncol Rep; 2014 Nov; 32(5):2031-7. PubMed ID: 25215901
[TBL] [Abstract][Full Text] [Related]
14. Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression.
González Díaz EC; Sinha S; Avedian RS; Yang F
Acta Biomater; 2019 Nov; 99():18-32. PubMed ID: 31419564
[TBL] [Abstract][Full Text] [Related]
15. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
Wang YT; Tang F; Hu X; Zheng CX; Gong TJ; Zhou Y; Luo Y; Min L
IUBMB Life; 2020 Oct; 72(10):2146-2153. PubMed ID: 33448097
[TBL] [Abstract][Full Text] [Related]
16. Engineering Novel 3D Models to Recreate High-Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment.
Pierrevelcin M; Flacher V; Mueller CG; Vauchelles R; Guerin E; Lhermitte B; Pencreach E; Reisch A; Muller Q; Doumard L; Boufenghour W; Klymchenko AS; Foppolo S; Nazon C; Weingertner N; Martin S; Briandet C; Laithier V; Di Marco A; Bund L; Obrecht A; Villa P; Dontenwill M; Entz-Werlé N
Adv Healthc Mater; 2022 Oct; 11(19):e2200195. PubMed ID: 36057996
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619.
Lavaud M; Mullard M; Tesfaye R; Amiaud J; Legrand M; Danieau G; Brion R; Morice S; Regnier L; Dupuy M; Brounais-Le Royer B; Lamoureux F; Ory B; Rédini F; Verrecchia F
Cells; 2021 Aug; 10(9):. PubMed ID: 34571917
[TBL] [Abstract][Full Text] [Related]
18. Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma.
Wagner F; Holzapfel BM; McGovern JA; Shafiee A; Baldwin JG; Martine LC; Lahr CA; Wunner FM; Friis T; Bas O; Boxberg M; Prodinger PM; Shokoohmand A; Moi D; Mazzieri R; Loessner D; Hutmacher DW
Biomaterials; 2018 Jul; 171():230-246. PubMed ID: 29705656
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficiency of photodynamic therapy for the treatment of osteosarcoma: A systematic review of in vitro experiment and animal model reports.
Tan G; Xu J; Yu Q; Yang Z; Zhang H
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103093. PubMed ID: 36031143
[TBL] [Abstract][Full Text] [Related]
20. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
